Methionine-Derived Metabolites in Apoptosis: Therapeutic Opportunities for Inhibitors of their Metabolism in Chemoresistant Cancer Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|28|3686-3700

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.28, 2009-10, pp. : 3686-3700

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Promotion of Apoptosis in Cancer Cells by Selective Purine-Derived Pharmacological CDK Inhibitors: One Outcome, Many Mechanisms

By  

Current Pharmaceutical Design, Vol. 17, Iss. 3, 2011-01 ,pp. : 256-271

Bentham Science Publishers

Access to resources Recommend Favorite

Reprogrammed Metabolism of Cancer Cells as a Potential Therapeutic Target

By  

Current Pharmaceutical Design, Vol. 20, Iss. 15, 2014-05 ,pp. : 2580-2594

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells

By Abu-Raya S.   Tabakman R.   Blaugrund E.   Trembovler V.   Lazarovici P.  

European Journal of Pharmacology, Vol. 434, Iss. 3, 2002-01 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite

JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells

By  

Current Cancer Drug Targets, Vol. 18, Iss. 8, 2018-10 ,pp. : 816-828

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacokinetic and Metabolism of PET Radiotracers for Imaging P-glycoprotein in Chemoresistant Tumor of Colorectal Cancer

By  

Current Drug Metabolism, Vol. 12, Iss. 10, 2011-12 ,pp. : 985-988

Bentham Science Publishers

Access to resources Recommend Favorite